The findings could help doctors identify cancer patients who would benefit the most from drugs called checkpoint blockade inhibitors.
Predictions from the OncoNPC model could enable doctors to choose targeted treatments for difficult-to-treat tumors.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer.
While developing targeted drug-delivery methods, the PhD student advocates for inclusion, belonging, and collaboration.
The chemical engineer is honored for her work designing polymers and nanomaterials with wide-ranging applications in medicine and energy.
With the new method, scientists can explore many cancer mutations whose roles are unknown, helping them develop new drugs that target those mutations.